ArticlePharmacoEconomics2015
Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation.
Alexander Mensch et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it